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Abstract 
Objective 
To evaluate the epidemiology, clinical 
characteristics and response to oral artemisinin-
based combination treatments (ACTs) of children 
with Plasmodium falciparum hyperparasitaemia 
(PfHP). 
Methods 
All children with febrile or history of febrile illness 
who were suspected to be malaria were evaluated for 
the presence of PfHP and their parasitological and 
clinical characteristics at presentation and follow-up 
for four weeks were recorded during a 3-year period. 
Patients were treated with oral artemisinin-baesd 
combination drugs. 
Results 
PfHP was present in 3% (97/3 338) of parasite-
positive children, and with no seasonal variation. 
The proportion of children with PfHP increased 
significantly over the years (P =0.001). Compared 
with non-hyperparasitaemic children, 
hyperparasitaemic children were younger, had 
significantly shorter duration of illness, and higher 
core temperature on presentation (P =0.04, 0.04, 
<0.000 1, respectively). Parasite clearance and half-
lives of parasitaemia were similar in both groups of 
children following treatment with artemether-
lumefantrine or artesunate-amodiaquine but half-life 
of parasitaemia increased significantly as parasite 
clearance time increased (P <0.000 1). The 
proportions of children in which there was no 
change in haematocrit following treatment with 
these drugs were similar (65% vs 76%, P =0.09), but 
fall in haematocrit/1 000 parasites cleared from 
peripheral blood was 10-fold higher in patients 
without hyperparasitaemia suggesting that 
artemether-lumefantrine or artesunate-amodiaquine 
may conserve haematocrit in children with 
hyperparasitaemia. Recrudescent infections were 
significantly more common in hyperparasitaemic 
children (P =0.014). 
Conclusions 
PfHP is common in young malarious Nigerian 
children, and severe malaria which is in the absence 
of other features responds promptly to oral ACTs. 
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